An intravenous, vascular disrupting agent for first- and second-line treatment of advanced non-small cell lung cancer.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An intravenous, vascular disrupting agent for first- and second-line treatment of advanced non-small cell lung cancer.
If you have a Hayes login, click here to view the full report on the Knowledge Center.